For medical device enterprises going global, U.S. FDA certification has always been a mandatory market entry threshold for North America. A 510(k) Substantial Equivalence Clearance Letter issued by the Center for Devices and Radiological Health (CDRH) under the U.S. Food and Drug Administration grants products legal eligibility to launch in the U.S. market. This article dissects the official FDA clearance document word for word, covering four core dimensions: official filing records, review logic, compliance specifications, and practical commercial applications, to help industry practitioners grasp the underlying compliance rules of FDA 510(k) for medical devices.
Issuing Authority: U.S. Food and Drug Administration (FDA); medical device reviews are administered by CDRH.
Clearance Issuance Date: The official date FDA releases the clearance letter.
Applicant (License Holder): Full corporate name, designated contact person, and registered address.
Exclusive FDA 510(k) File Number:Identified by a prefix "K", this unique tracking ID is assigned by the FDA to each Premarket Notification 510(k) submission. It is used to track, manage, and publicly verify the market access status of medical devices across the entire FDA system, enabling full traceability of products via this number.